Regulation of metastasis by microRNAs in ovarian cancer

Ovarian cancer (OC) is the second most common and the most fatal gynecologic cancer in the United States. Over the last decade, various targeted therapeutics have been introduced but there has been no corresponding improvement in patient survival mainly because of the lack of effective early detecti...

Full description

Bibliographic Details
Main Authors: Yongchao eWang, Sangmi eKim, IL-MAN eKIM
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00143/full
id doaj-df8d09dcad774891ab2d7fbcaaeba086
record_format Article
spelling doaj-df8d09dcad774891ab2d7fbcaaeba0862020-11-25T01:37:02ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2014-06-01410.3389/fonc.2014.0014397178Regulation of metastasis by microRNAs in ovarian cancerYongchao eWang0Sangmi eKim1IL-MAN eKIM2Georgia Regents UniversityGeorgia Regents UniversityGeorgia Regents UniversityOvarian cancer (OC) is the second most common and the most fatal gynecologic cancer in the United States. Over the last decade, various targeted therapeutics have been introduced but there has been no corresponding improvement in patient survival mainly because of the lack of effective early detection methods. MicroRNAs (miRs) are small, non-coding RNAs that regulate gene expression post-transcriptionally. Accumulating data suggest central regulatory roles of miRs in modulating OC initiation, progression and metastasis. More recently, aberrant miR expression has been also associated with cancer stem cell (CSC) phenotypes and development of CSC chemo-resistance. Here, we review recent advances on miRs and OC metastasis and discuss the concept that miRs are involved in both CSC transformation and subsequent OC metastasis. Finally, we describe the prevalence of circulating miRs and assess their potential utilities as biomarkers for OC diagnosis, prognosis, and therapeutics.http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00143/fullEpithelial-Mesenchymal TransitionExtracellular MatrixAngiogenesiscancer stem cellsovarian cancermiRs
collection DOAJ
language English
format Article
sources DOAJ
author Yongchao eWang
Sangmi eKim
IL-MAN eKIM
spellingShingle Yongchao eWang
Sangmi eKim
IL-MAN eKIM
Regulation of metastasis by microRNAs in ovarian cancer
Frontiers in Oncology
Epithelial-Mesenchymal Transition
Extracellular Matrix
Angiogenesis
cancer stem cells
ovarian cancer
miRs
author_facet Yongchao eWang
Sangmi eKim
IL-MAN eKIM
author_sort Yongchao eWang
title Regulation of metastasis by microRNAs in ovarian cancer
title_short Regulation of metastasis by microRNAs in ovarian cancer
title_full Regulation of metastasis by microRNAs in ovarian cancer
title_fullStr Regulation of metastasis by microRNAs in ovarian cancer
title_full_unstemmed Regulation of metastasis by microRNAs in ovarian cancer
title_sort regulation of metastasis by micrornas in ovarian cancer
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2014-06-01
description Ovarian cancer (OC) is the second most common and the most fatal gynecologic cancer in the United States. Over the last decade, various targeted therapeutics have been introduced but there has been no corresponding improvement in patient survival mainly because of the lack of effective early detection methods. MicroRNAs (miRs) are small, non-coding RNAs that regulate gene expression post-transcriptionally. Accumulating data suggest central regulatory roles of miRs in modulating OC initiation, progression and metastasis. More recently, aberrant miR expression has been also associated with cancer stem cell (CSC) phenotypes and development of CSC chemo-resistance. Here, we review recent advances on miRs and OC metastasis and discuss the concept that miRs are involved in both CSC transformation and subsequent OC metastasis. Finally, we describe the prevalence of circulating miRs and assess their potential utilities as biomarkers for OC diagnosis, prognosis, and therapeutics.
topic Epithelial-Mesenchymal Transition
Extracellular Matrix
Angiogenesis
cancer stem cells
ovarian cancer
miRs
url http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00143/full
work_keys_str_mv AT yongchaoewang regulationofmetastasisbymicrornasinovariancancer
AT sangmiekim regulationofmetastasisbymicrornasinovariancancer
AT ilmanekim regulationofmetastasisbymicrornasinovariancancer
_version_ 1725060014800896000